Article
Characterisation of the cardiac kallikrein-kinin system in transgenic rats expressing the human KLK-1 gene
Charakterisierung des kardialen Kallikrein-Kinin-Systems bei transgenen Ratten mit Expression des humanen hKLK-1 Gens
Search Medline for
Authors
Published: | August 10, 2005 |
---|
Outline
Text
Objective: The kallikrein-kinin system (KKS) is an established myocardial protection system under ischemic conditions. We analyzed the bradykinin (BK) content in the coronary outflow ex vivo and the BK receptor regulation and capillary density in vivo in transgenic rats harbouring the human tissue kallikreine-1 gene TGR(hKLK1) compared to wild-type Spraque Dawley rats under basal conditions
Methods: Coronary outflow of buffer-perfused isolated hearts of controls and TGR(hKLK1) was immediately supplemented with 1% triflouroacetic acid. And BK content was quantitated by a specific radioimmunoassay. The expression of BK B1 und B2 receptor mRNA was detected by a ribonuclease protection assay with GAPDH mRNA as a housekeeping gene. CD31 expression as a marker for cardiac capillary density was analyzed by immunohistochemical staining and quantified by digital image analysis.
Results: Basal BK content was 3.5-fold increased in TGR(hKLK1) (0.98±0.20 pg/ml vs. 0.28±0.08 pg/ml; p<0.01) compared to controls. Also expression of BK receptor mRNA was significantly increased in TGR(hKLK1) (B1-Rezeptor: 316±42 vs. 100±41%; B2: 394±9 vs. 100±16%). This was accompanied by a significant higher CD31 expression in TGR(hKLK1) (Area fraction: 0.03 (0.02 -0.05) vs. 0.06 (0.04 - 0.08); p<0.05).
Conclusion: We detected both an increased basal BK content as well as an higher BK receptor expression in our TGR(hKLK1) model, indicating an activated KKS. The KKS upregulation was accompanied by a pro-angiogenetic effect with higher capillary density.